Olga Rudenko

Olga Rudenko serves as a Research Consultant and Guest Researcher with the Schwartz Group at the University of Copenhagen's Faculty of Health and Medical Sciences. Her work bridges neuroscience, metabolism, and endocrine signaling, focusing on molecular mechanisms underlying metabolic disorders and neurodegenerative conditions.

Dr. Rudenko's research spans several critical areas in biomedical science:

• Neuroendocrinology, particularly ghrelin signaling pathways and their dual role in metabolic regulation and neurological function
• GPCR-mediated metabolite signaling and its impact on pancreatic and gut hormone regulation
• Behavioral neuroscience with emphasis on Huntington's disease models and anxiety-related pathways
• Microbiome-metabolism interactions, especially how microbial fermentation affects metabolic health
• Development of innovative methodologies for automated behavioral analysis and cell motility assessment

Her publication record demonstrates consistent contributions to understanding molecular pathways in metabolic disorders. Notably, her co-authored 2017 Cell Metabolism review on GPCR signaling has accumulated over 450 citations, reflecting significant impact in the field. Her work frequently appears in high-impact journals including Molecular Metabolism and American Journal of Physiology, with several publications receiving attention from news outlets and academic platforms.

As a member of the Schwartz Group, Dr. Rudenko contributes to a research environment renowned for pioneering work in receptor pharmacology. Her collaborative approach is evident through extensive co-authorship with leading researchers including T.W. Schwartz and B. Holst, suggesting integration within a productive research network focused on metabolic signaling pathways with therapeutic implications for obesity, Huntington's disease, and anxiety disorders.